156 related articles for article (PubMed ID: 34017084)
21. Functional and biochemical changes in the thyroid gland following exposure to therapeutic doses of external beam radiotherapy in the head-and-neck cancer patients.
Randhawa AS; Yadav HP; Banipal RPS; Goyal G; Garg P; Marcus S
J Cancer Res Ther; 2021; 17(4):1025-1030. PubMed ID: 34528559
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
Kubota H; Miyawaki D; Mukumoto N; Ishihara T; Matsumura M; Hasegawa T; Akashi M; Kiyota N; Shinomiya H; Teshima M; Nibu KI; Sasaki R
Radiat Oncol; 2021 Jan; 16(1):1. PubMed ID: 33402192
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Ahn D; Lee GJ; Sohn JH; Lee JE
Cancer Med; 2020 Dec; 9(24):9256-9265. PubMed ID: 33073917
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
[TBL] [Abstract][Full Text] [Related]
26. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
27. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
[TBL] [Abstract][Full Text] [Related]
28. Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
Sun XS; Tao Y; Le Tourneau C; Pointreau Y; Sire C; Kaminsky MC; Coutte A; Alfonsi M; Boisselier P; Martin L; Miroir J; Ramee JF; Delord JP; Clatot F; Rolland F; Villa J; Magne N; Elicin O; Gherga E; Nguyen F; Lafond C; Bera G; Calugaru V; Geoffrois L; Chauffert B; Zubel A; Zanna C; Brienza S; Crompton P; Rouits E; Gollmer K; Szyldergemajn S; Bourhis J
Lancet Oncol; 2020 Sep; 21(9):1173-1187. PubMed ID: 32758455
[TBL] [Abstract][Full Text] [Related]
29. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
30. Use of
Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
[No Abstract] [Full Text] [Related]
31. Peripheral Cytokine Levels Differ by HPV Status and Change Treatment-Dependently in Patients with Head and Neck Squamous Cell Carcinoma.
Mytilineos D; Ezić J; von Witzleben A; Mytilineos J; Lotfi R; Fürst D; Tsamadou C; Theodoraki MN; Oster A; Völkel G; Kestler HA; Brunner C; Schuler PJ; Doescher J; Hoffmann TK; Laban S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825343
[TBL] [Abstract][Full Text] [Related]
32. Trends in all-cause five-year mortality after head and neck cancers diagnosed over a period of 33 years. Focus on estimated degree of association with human papillomavirus.
Svahn MF; Munk C; Nielsen TS; von Buchwald C; Frederiksen K; Kjaer SK
Acta Oncol; 2016; 55(9-10):1084-1090. PubMed ID: 27550781
[TBL] [Abstract][Full Text] [Related]
33. Chronic sinusitis in head and neck cancer patients who received radiotherapy or chemoradiotherapy.
Park YM; Cho JG; Woo JS
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2805-2811. PubMed ID: 30167838
[TBL] [Abstract][Full Text] [Related]
34. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.
Berggren KL; Restrepo Cruz S; Hixon MD; Cowan AT; Keysar SB; Craig S; James J; Barry M; Ozbun MA; Jimeno A; McCance DJ; Beswick EJ; Gan GN
Oncogene; 2019 Nov; 38(48):7329-7341. PubMed ID: 31417185
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
36. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.
Ferris RL; Geiger JL; Trivedi S; Schmitt NC; Heron DE; Johnson JT; Kim S; Duvvuri U; Clump DA; Bauman JE; Ohr JP; Gooding WE; Argiris A
Ann Oncol; 2016 Dec; 27(12):2257-2262. PubMed ID: 27733374
[TBL] [Abstract][Full Text] [Related]
38. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
[TBL] [Abstract][Full Text] [Related]
39. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
Cramer JD; Ferris RL; Kim S; Duvvuri U
Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
